Antibodies News and Research

RSS

Brain tumors hijack healthy neurons in order to grow

Scientists have discovered that brain tumors integrate themselves with the brain’s healthy neuronal network to support their growth.

19 Sep 2019

Embryonic damage due to autoantibodies could be cause of behavioral disorders in the child

Dysfunctions in the maternal immune system that occur during pregnancy could possibly lead to impaired brain development in the unborn child.

18 Sep 2019

Quanterix Serum Nf-L assay powers key trial and study results presented at ECTRIMS 2019

Quanterix, announce that its Simoa technology and Nf-L assays were used in many of the groundbreaking research and treatment developments.

From Quanterix 18 Sep 2019

Researchers receive $12 million grant to develop flu vaccine against many viral strains

Patrick Wilson, PhD, professor of medicine and rheumatology at the University of Chicago, and a group of researchers from three other institutions have received a Grand Challenge for Universal Influenza Vaccine Development grant – a $12 million initiative funded by the Bill & Melinda Gates Foundation and Flu Lab.

18 Sep 2019

Researchers develop new anti-cancer nanomedicine for targeted chemotherapy

Researchers at the University of Helsinki in collaboration with researchers from Åbo Akademi University, Finland and Huazhong University of Science and Technology, China have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

17 Sep 2019

Mutant live attenuated Ebola virus elicits protective immunity in monkeys

Inoculation with an Ebola virus that has mutations in a protein called VP35 does not cause disease and elicits protection in monkeys, researchers show September 17 in the journal Cell Reports.

17 Sep 2019

Clinically undetectable Plasmodium relapse infections may still pose a threat

Nonhuman primates with clinically undetectable Plasmodium relapse infections still harbor parasitic gametocytes that may be infectious to mosquitoes, according to a study published September 19 in the open-access journal PLOS Pathogens by F. Eun-Hyung Lee and Mary R. Galinski of Emory University, Tracey J. Lamb of the University of Utah, and colleagues.

From PLOS ONE 17 Sep 2019

World Alzheimer’s Day 2019: A timely reminder of urgent need for new drugs to tackle disease

As World Alzheimer’s Day 2019 approaches (21 September), with the aim this year of raising global awareness and understanding of the stigma, stereotypes and myths that surround a dementia diagnosis;

17 Sep 2019

No more tears: immunization without needles

A new study published in the Journal of Investigative Dermatology reports a novel skin vaccine patch which could help effective and safe immunization by disrupting the permeability of the skin, providing a convenient and non-invasive alternative to immunization shots. This innovative technique now needs to be tested in humans.

17 Sep 2019

Uncovering new T cell regulatory processes could help treat autoimmune disease

One of the important cells involved in the immune response is the T follicular helper (Tfh) cell. These are important in the normal process of antibody production following immunization, for instance. However, they are also abnormally increased in number in patients with autoimmune disease, such as systemic lupus erythematosus.

16 Sep 2019

Experts offer insights into new class of migraine medications

As research continues to show progress towards minimizing the effects of headache disorders on patients' lives, Practical Neurology gathered insights from experts in the field at The American Headache Society 61st Annual Scientific Meeting this year, where new data looking at a range of approaches from nerve stimulation to monoclonal antibodies and neuromodulation devices revealed advancements in migraine treatment.

16 Sep 2019

Researchers eliminate need for anti-rejection drugs in mice with transplanted glial cells

In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

16 Sep 2019

Atlas Antibodies presents QPrEST standards for absolute quantification of proteins using mass spectrometry

Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography (LC)–mass spectrometry (MS).

From Atlas Antibodies 16 Sep 2019

Study shows how the interplay of two cytokines affects development of Tfh cells

The body's immune response fights against infectious disease, and it safeguards against future infections through vaccination.

15 Sep 2019

Study shows how the immune system achieves antibody diversity

Diversity is good, especially when it comes to antibodies. It's long been known that a gene assembly process called V(D)J recombination allows our immune system to mix and match bits of genetic code, generating new antibodies to conquer newly encountered threats.

15 Sep 2019